Human Cadherin EGF LAG seven-pass G-type receptor 3 (CELSR3) ELISA Kit

Product specifications

ELISA Kits

Cadherin EGF LAG seven-pass G-type receptor 3 (CELSR3)

Human

Colorimetric

Quantitative

0.156 ng/ml - 10 ng/ml

Optimal dilutions/concentrations should be determined by the end user.

96 tests

Lyophilized

ELISA

Tissue homogenates, cell lysates and other biological fluids.

Shipped within 5-15 working days. The validity for this kit is 6 months.

Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.

No

Q9NYQ7

CELSR3,ADGRC3,MEGF2,multiple epidermal growth factor-like domains 2,CDHF11, EGFL1, FMI1, HFMI1,RESDA1

Elisa kits for CELSR3

RUO

Validity: The validity for this kit is 6 months.

This product is for research use only.   The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.   Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.

Descripción

CELSR3 encodes Cadherin EGF LAG seven-pass G-type receptor 3, a vital adhesion GPCR involved in the establishment of neuronal connectivity and axonal guidance. CELSR3 plays an essential role in the Wnt/planar cell polarity (PCP) pathway and regulates the development of neural circuits, particularly in the central nervous system. It is highly expressed in the developing brain and is crucial for processes such as neuronal migration, axon pathfinding, and dendrite orientation. CELSR3 is indispensable for the formation of major neural tracts like the thalamocortical and corticospinal pathways, which are necessary for sensory processing and motor control. Disruptions in CELSR3 lead to severe neurological disorders, including congenital brain malformations and epilepsy. Mutations in CELSR3 have also been linked to intellectual disabilities and schizophrenia, conditions that arise from impaired neuronal connectivity. Beyond its developmental role, CELSR3 has been implicated in glioblastoma and other cancers, where it promotes tumor cell invasion and loss of cell polarity. CELSR3's structure includes cadherin repeats and EGF-like domains that allow it to facilitate cell adhesion and signaling, highlighting its importance in both neurodevelopment and disease.

Related Products

Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody

Rabbit polyclonal antibody against CELSR3 protein. Immunogen region is C-terminal.

Ver Producto

Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody

Cadherin EGF LAG Seven Pass G-Type Receptor 3 Antibody is a Rabbit Polyclonal against Cadherin EGF LAG Seven Pass G-Type Receptor 3.

Ver Producto

Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Antibody

Cadherin EGF LAG Seven Pass G-Type Receptor 3 Antibody is a Rabbit Polyclonal against Cadherin EGF LAG Seven Pass G-Type Receptor 3.

Ver Producto